Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The processes of DNA, RNA, and protein synthesis—often collectively termed "gene expression machinery"—are central to all living cells. DNA synthesis (replication) copies genetic material, RNA synthesis (transcription) converts DNA information into messenger RNA (mRNA), and protein synthesis (translation) decodes mRNA to build proteins, typically at the ribosome. These processes underpin cellular function, heredity, and adaptation, and are targeted by many classes of drugs, including antibiotics, antivirals, and chemotherapies[4][1][6]. Defects or dysregulation in these pathways are central to the development of cancer and numerous genetic diseases.
Inhibition of transcription (e.g., rifampicin blocks bacterial RNA polymerase) Inhibition of translation (e.g., aminoglycosides block ribosomal function) DNA damage and crosslinking (e.g., chemotherapy drugs) Nucleic acid analog incorporation (antivirals/antimetabolites)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA, RNA, and protein synthesis machinery.